For the Inventor, By the Inventor

Enter assignee name

Sclavo Spa

USPTO Granted Patents = 44

CIPO Patents = 1

Forward Citations = 833

Loading Chart...

Loading Chart...

96 inventors (with patents filed for the assignee):

Antonio S Verdini (9 out of 35 patents)

Paolo Tarli (4 out of 8 patents)

Rino Rappuoli (3 out of 82 patents)

4. Massimo Pinori (3 out of 13 patents)

5. Luciano Nencioni (3 out of 5 patents)

6. Alessandro Sisto (3 out of 15 patents)

7. Marzia Monica Giuliani (3 out of 29 patents)

8. Mario F Tecce (3 out of 5 patents)

9. Felice Centini (3 out of 6 patents)

10. Franco Cardinali (3 out of 3 patents)

11. Giuseppe C Viscomi (3 out of 3 patents)

12. Diana Boraschi (3 out of 3 patents)

13. Paolo Fabrizi (3 out of 3 patents)

14. Alessandro Tabacco (3 out of 4 patents)

15. Claudio Fuganti (2 out of 15 patents)

Core Competencies:

Vaccine Development

Peptide Synthesis

Protein Purification

Immunological Activity

Collagenase Solutions

Thymopentin Analogues

Enzyme Isolation

Synthetic Nonapeptides

Microorganism Identification

Chromatographic Supports

Glucose Determination

Toxicity Proteins

44 patents: Sort by Forward Citations

1. 6096519 - Chlamydia trachomatis serotype D proteins (2000-08-01),

2. 5622706 - Cloning and sequencing of the gene which codes for a new pilinic subunit (1997-04-22),

3. 5432082 - Expression and secretion vector in yeasts, useful for preparing (1995-07-11),

4. 5427788 - Pertussis toxin and use in vaccines (1995-06-27),

5. 5378365 - Process for the isolation of highly purified factors IX, X and II from (1995-01-03),

6. 5300427 - Buffer solutions containing collagenase, their preparation and use for (1994-04-05),

7. 5284937 - Process for the extraction and purification of human recombinant gamma (1994-02-08),

8. 5279944 - Method and reagent composition for the determination of alanine (1994-01-18),

9. 5259951 - Process for the purification of factor VIII and factor VIII obtained by (1993-11-09),

10. 5244655 - Process for the purification of recombinant human beta interferon, beta (1993-09-14),

11. 5229367 - Antiinflammatory peptide derived from human lipocortin V (1993-07-20),

12. 5219988 - Gem-diamino derivatives and their use in the synthesis of retro-inverso (1993-06-15),

13. 5218089 - Retro-inverso analogues of thymopentin and the method for their synthesis (1993-06-08),

14. 5206164 - DNA encoding a synthetic peptide endowed with immunological activity and (1993-04-27),

15. 5206014 - Synthetic nonapeptide for use as an adjuvant (1993-04-27),

Company Overview

Sclavo Spa, based in Siena, Italy, specializes in the development and manufacturing of innovative biopharmaceutical products. The company focuses on advanced research in areas such as Chlamydia Trachomatis, pertussis toxin, and recombinant proteins, contributing to the field of immunology and vaccine composition. Sclavo Spa is also engaged in the creation of synthetic peptides and retro-inverso peptides, enhancing non-invasive monitoring techniques and advancing therapeutic solutions in infectious diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

44 Patents

#3 in Siena

#211 in Italy

#15,768 in the World

Sclavo Spa

Forward Citations = 833

96 inventors:

Antonio S Verdini (9 out of 35 patents)

Paolo Tarli (4 out of 8 patents)

Rino Rappuoli (3 out of 82 patents)

4. Massimo Pinori (3 out of 13 patents)

5. Luciano Nencioni (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sclavo Spa. Retrieved from https://idiyas.com/company/sclavo-spa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…